Skip to main content
. 2015 Dec 1;2(1):e000290. doi: 10.1136/openhrt-2015-000290

Table 2.

Characteristics of patients hospitalised with AF in France in 2012 (all p<0.001)

Patients discharged alive
n=482 879
Patients who died during hospitalisation
n=50 165
Age, mean (SD), years 77.6±11.5 82.3±9.3
Women, % 47.1 47.6
Cumulative length of stay in hospital (or to death), median (IQR), median (IQR), days 9.0 (4.0–17.0) 14.0 (6.0–28.0)
Comorbidities*, %
 Alcohol-related diagnosis 5.9 7.5
 Anaemia 22.6 35.5
 Cancer in preceding 5 years 17.8 30.2
 Diabetes mellitus 24.0 26.7
 Hypertension 69.9 73.0
 Inflammatory disease 9.5 11.9
 Liver failure 4.3 8.8
 Lung disease 21.3 34.2
 Neurological disease 9.9 15.6
 Renal failure 21.2 39.1
 Thyroid disease 13.3 14.3
Cardiovascular history (%)
 Stroke 7.9 9.6
  Ischaemic 6.2 7.3
  Haemorrhagic 1.1 1.5
  Unspecified 1.6 2.2
 Major haemorrhage† 2.4 3.3
  Intracranial 0.5 0.7
  Gastrointestinal 0.9 1.5
  Any severe bleeding 1.1 1.5
 Systemic embolism 3.0 4.4
 Transient ischaemic attack 3.0 3.3
 Vascular disease 17.2 22.4
  Myocardial infarction 7.8 9.6
  Peripheral artery disease 9.4 13.4
  Occlusion of precerebral artery or other arterial disorder 4.2 5.7
  Other ischaemic heart disease 21.7 25.6
  Symptoms of AF leading to hospitalisation 7.4 6.5
 Heart failure 28.3 41.8
 Cardiac dysrhythmia 7.6 8.3
 Abnormal cardiac conduction 16.0 18.9
 Valvular disease/surgery 13.5 17.3
 Mitral stenosis 0.8 0.9
Accidental falls 9.5 15.4
Risk scores
 CHA2DS2-VASc, mean (SD) 4.0 (1.8) 4.6 (1.6)
 CHA2DS2-VASc, median (IQR) 4.0 (3.0–5.0) 5.0 (4.0–6.0)
  Score 0–3, % 38.6 24.3
  Score 4–6, % 53.8 63.9
  Score 7–9, % 7.6 11.8
 HAS-BLED, mean (SD) 2.1 (1.1) 2.6 (1.1)
 HAS-BLED, median (IQR) 2.0 (1.0–3.0) 2.0 (2.0–3.0)
  Score 0–2, % 68.2 50.4
  Score ≥3% 31.8 49.6

*From the International Classification of Disease 10th edition (ICD-10) codes (see online supplementary table S1).

†Bleeding leading to a hospitalisation: intracranial haemorrhage, gastrointestinal haemorrhage, other major bleeding.

AF, atrial fibrillation; CHA2DS2-VASc, Cardiac failure or dysfunction, Hypertension, Age ≥75 (Doubled), Diabetes, Stroke (Doubled)-Vascular disease, Age 65–74 and Sex category (Female); HAS-BLED, Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalised ratio (INR), Elderly, Drugs/alcohol concomitantly.